These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 17948211

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy.
    Blais L, Sheehy O, St-Hilaire JM, Bernier G, Godfroid P, LeLorier JJ.
    Pharmacoeconomics; 2005; 23(5):493-503. PubMed ID: 15896100
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: a comparative short-term study.
    Ciesielski AS, Samson S, Steinhoff BJ.
    Epilepsy Behav; 2006 Nov; 9(3):424-31. PubMed ID: 16949344
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A cost-effectiveness analysis of the effect of pregabalin versus usual care in the treatment of refractory neuropathic pain in routine medical practice in Spain.
    de Salas-Cansado M, Pérez C, Saldaña MT, Navarro A, Rejas J.
    Pain Med; 2012 May; 13(5):699-710. PubMed ID: 22594706
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: a randomized, double-blind, noninferiority trial.
    Zaccara G, Almas M, Pitman V, Knapp L, Posner H.
    Epilepsia; 2014 Jul; 55(7):1048-57. PubMed ID: 24902473
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy.
    Tanaka S, Tanaka T.
    Epileptic Disord; 2013 Jun; 15(2):132-41. PubMed ID: 23774199
    [Abstract] [Full Text] [Related]

  • 16. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures.
    Arroyo S, Anhut H, Kugler AR, Lee CM, Knapp LE, Garofalo EA, Messmer S, Pregabalin 1008-011 International Study Group.
    Epilepsia; 2004 Jan; 45(1):20-7. PubMed ID: 14692903
    [Abstract] [Full Text] [Related]

  • 17. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I.
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [Abstract] [Full Text] [Related]

  • 18. Seizure-free days observed in randomized placebo-controlled add-on trials with levetiracetam in partial epilepsy.
    Leppik I, Morrell M, Godfroid P, Arrigo C.
    Epilepsia; 2003 Oct; 44(10):1350-2. PubMed ID: 14510829
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
    Kinirons P, McCarthy M, Doherty CP, Delanty N.
    Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.